1 Flexible Endoscopy Equipment Market Revenue Share of Top 3 Players (2018-2023)
Olympus Corporation’s performance in the global flexible endoscopy equipment market demonstrates its strong position as an industry leader. From 2018 to 2023, Olympus’s market share fluctuated slightly but generally remained high. Specifically, Olympus’ market share was 48.39% in 2018, followed by a slight decline to 47.67% in 2019. However, by 2020, market share rebounded to 48.36% and increased further to 48.76% in 2021. In 2022, Olympus’ market share reached its peak in recent years at 49.51%. Despite a slight decline to 49.35% in 2023, this percentage still demonstrates Olympus’ significant position in the global market. This consistently high market share reflects Olympus’ continued investment and strengths in technological innovation, product quality, customer service and global distribution network, enabling it to maintain its leadership position in the global market for flexible endoscopy equipment.
FUJIFILM Medical Systems’ share in the global flexible endoscopy equipment market shows some stability and minor fluctuations. Starting from 16.23% in 2018, the company’s market share declined slightly to 15.88% in 2019, followed by a further decline to 15.71% in 2020. However, by 2021, the market share has recovered to 16.64%. Despite a slight decline to 16.49% and 16.53% in 2022 and 2023, respectively, overall, FUJIFILM Medical Systems’ market share fluctuated between 15% and 17%, demonstrating its competitiveness and relatively stable market position in the global market. This fluctuation may be due to changes in the competitive market environment and internal strategic adjustments within the company. Nonetheless, FUJIFILM Medical Systems has maintained a relatively stable market share as a key player in the global flexible endoscopy equipment market, which may be attributed to its continuous investment and efforts in medical imaging technology and product innovation.
HOYA’s share of the global flexible endoscopy equipment market experienced slight fluctuations but remained stable overall and showed a slow growth trend. In 2018, HOYA’s market share stood at 15.14%, followed by a slight increase to 15.26% in 2019. Despite a slight decline to 14.92% in 2020, the company resumed growth in 2021 with a market share of 15.17%. This growth trend continues through 2022, when market share increases to 15.36%, and further rises to 15.59% in 2023. These figures show that despite increasing competition in the market, HOYA has been able to strengthen its market position through market expansion strategies. From 2018 to 2023, HOYA’s market share has remained between 14% and 16%, demonstrating its stable competitiveness in the flexible endoscopy equipment market. This steady growth can be attributed to the company’s active investment and efforts in product development, market strategies, and customer service, which has enabled HOYA to maintain its position as a key player in the global flexible endoscopy equipment market.
Table Global Flexible Endoscopy Equipment Revenue Share of Key Players (2018-2023)
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Olympus Corporation | 48.39% | 47.67% | 48.36% | 48.76% | 49.51% | 49.35% |
FUJIFILM Medical Systems | 16.23% | 15.88% | 15.71% | 16.64% | 16.49% | 16.53% |
HOYA | 15.14% | 15.26% | 14.92% | 15.17% | 15.36% | 15.59% |
2 Olympus Corporation
Olympus Corporation is a Japanese company founded in 1919 that specializes in enhancing the quality of patient care through the development and design of advanced precision technologies and services. The company’s medical specialties include otolaryngology, gastroenterology, general surgery, gynecology, neurosurgery, pulmonology, and urology. Olympus provides medical solutions covering hygiene and reprocessing, operating room integration, endoscopic therapy, and transnasal endoscopy. Its products enable healthcare professionals from a variety of specialties to use endoscopic procedures for in vivo treatment, focusing on the early detection and minimally invasive treatment of a wide range of diseases. Olympus Corporation’s flexible endoscopy products support physicians with enhanced maneuverability and advanced diagnostic capabilities to achieve more precise operations and optimize patient outcomes. Its product line includes diagnostic scopes, such as traditional fiberscopes, SD videoscopes, which offer a good balance between image quality and fine diameter in the evolution of endoscopy, and HD videoscopes, which offer the best image quality on the market and are well suited for advanced endoscopy and early cancer detection. Olympus Corporation maintains a leading position in the global flexible endoscopy market through its broad product portfolio and technological innovations, and is committed to providing high-quality endoscopic equipment and services to healthcare professionals.
Table Olympus Corporation Basic Information
Item | Description | |
1 | Company Name | Olympus Corporation |
2 | Website | |
3 | Established Time | 1919 |
4 | Business Overview | Olympus is focused on improving the quality of patient care by developing and designing advanced precision technologies and services to achieve this goal. The medical specialties served by the company are otolaryngology, gastroenterology, general surgery, gynecology, neurosurgery, pulmonology and urology. Medical solutions include hygiene and reprocessing, OR integration, endoscopic therapy and transnasal endoscopy. The company’s products enable healthcare professionals from a wide range of specialties to use endoscopic procedures to treat within the body, focusing on the early detection and minimally invasive treatment of a wide range of diseases. |
5 | Headquarters | Japan |
6 | Market Distribution | Worldwide |
Table Olympus Corporation Flexible Endoscopy Equipment Product and Services
Flexible Endoscopy |
With enhanced maneuverability and advanced diagnostic capabilities, Olympus flexible endoscopes support doctors in achieving greater precision and optimizing patient outcomes. Diagnostic Scopes Fiberscope Fiberscopes have long been regarded as a gold standard in ENT endoscopy. For those in need for basic endoscopy, this remains an excellent instrument choice. SD Videoscope With the advancement in medical imaging technology, SD videoscopes present the next step in endoscopy evolution. Olympus SD videoscopes offer a great compromise between slim diameter and image quality. HD Videoscope HD videoscopes offer the best possible image quality on the market. With optimal illumination and HD resolution, Olympus videoscopes are best suited for advanced endoscopy and early cancer detection. |
Olympus Corporation has demonstrated solid growth and profitability in terms of volume, price, revenue, and gross margin in the global flexible endoscopy equipment market. From 2018 to 2023, Olympus Corporation’s sales volume grew from 14.0 K Units to 20.3 K Units, showing that the demand for the company’s products in the market has been increasing every year. In terms of price, despite fluctuations, the overall trend is relatively stable, decreasing slightly from $159.5 thousand per unit in 2018 to $152.0 thousand per unit in 2023. Despite the decline in unit prices, the Company’s operating income increased from $224 Million in 2018 to $309 Million in 2023, reflecting the positive impact of the Company’s increased sales volume on total revenue. In terms of gross margins, Olympus Corporation has maintained high levels, consistently above 74% despite fluctuations in different years, reaching 76.37% in 2023. These figures indicate that Olympus Corporation has not only been successful in increasing its sales volume, but has also performed well in maintaining its profitability, which can be attributed to its continued investment in product quality, technological innovation, and market positioning. Overall, Olympus Corporation’s sales performance and financial position in the global market for flexible endoscopic equipment demonstrate the company’s strong competitiveness and favorable market position.
Table Olympus Corporation Flexible Endoscopy Equipment Sales Volume, Price, Revenue, Gross Margin (2018-2023)
Olympus Corporation | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Sales (K Units) | 14.0 | 14.5 | 13.8 | 16.2 | 18.7 | 20.3 |
Price (K USD/Unit) | 159.5 | 157.8 | 161.3 | 157.4 | 153.6 | 152.0 |
Revenue (M USD) | 2.24 | 2.29 | 2.22 | 2.55 | 2.87 | 3.09 |
Gross (M USD) | 1.73 | 1.81 | 1.66 | 1.93 | 2.13 | 2.36 |
Gross Margin | 77.26% | 79.08% | 74.76% | 75.78% | 74.33% | 76.37% |
3 FUJIFILM Medical Systems
FUJIFILM Medical Systems is a Japanese company founded in 1934 that specializes in providing medical imaging and information technology products to serve the diagnostic imaging market. The company’s products and technologies are used in the acquisition, processing, management and storage of diagnostic images and related data. FUJIFILM Medical Systems’ major products include radiography systems, cardiovascular systems, direct radiography (DR) systems, computed radiography (CR) systems (digital X-ray), endoscopes, digital mammography systems and ultrasound systems. In addition, the company provides education and technical support services.
In the field of flexible endoscopic devices, FUJIFILM Medical Systems leads the market with its ELUXEO® endoscopic imaging system, which is based on the company’s long experience in medical image engineering and the introduction of LED multi-light source technology in 2018. The ELUXEO system offers, through an optimized combination of LED light sources, the ability to illuminate the endoscopes in both white light as well as clinically proven special light modes, including linked color imaging (LCI®) for enhanced adenoma detection and blue light imaging (BLI) for enhanced lesion characterization. Since the launch of the ELUXEO system, FUJIFILM has further introduced the 700 series of colonoscopes and gastroscopes, which, when used in conjunction with the ELUXEO Endoscopic Imaging System, provide endoscopists with unparalleled image clarity and visualization, along with excellent scope control, maneuverability, precision and ergonomics. Through these innovative products, FUJIFILM Medical Systems has gained a strong foothold in the global market for flexible endoscopic equipment and continues to push the boundaries of endoscopic technology.
Table FUJIFILM Medical Systems Basic Information
Item | Description | |
1 | Company Name | FUJIFILM Medical Systems |
2 | Website | |
3 | Established Time | 1934 |
4 | Business Overview | FUJIFILM Medical Systems is a provider of medical imaging and information products and technologies for the diagnostic imaging markets. The company’s products and technologies find application in acquiring, processing, managing and storing diagnostic images and related data. Fujifilm Medical’s offers major products include radiology systems, cardiovascular systems, direct radiography (DR) systems, computed radiology (CR) systems (digital X-ray), endoscopes, digital mammography systems, and ultrasound systems. It also provides education and technical support services. |
5 | Headquarters | Japan |
6 | Market Distribution | Worldwide |
Table FUJIFILM Medical Systems Flexible Endoscopy Equipment Product and Services
|
ELUXEO® Endoscopic Imaging System A powerful video imaging system is the foundation of any advanced endoscopic platform. Fujifilm’s long-standing experience in medical image engineering led to the pioneering of LED Multi-Light technology in Endoscopy in 2018 with the introduction of the ELUXEO® Endoscopic Imaging System. With ELUXEO, Fujifilm is the first to achieve optimal illumination that enhances endoscopic visualization and image clarity. The ideal output combination of individual LEDs has been developed to achieve optimal results in White Light as well as clinically proven special light observation modes: Linked Color Imaging (LCI®) to enhance adenoma detection and Blue Light Imaging (BLI) to enhance characterization of lesions. Since then, Fujifilm has introduced a comprehensive line of 700 Series colonoscopes and gastroscopes that, when used in combination with the ELUXEO Endoscopic Imaging System, provide endoscopists with an unmatched combination of image clarity and visualization with exceptional scope control, maneuverability, precision, and ergonomics. |
FUJIFILM Medical Systems’ performance in the flexible endoscopic devices segment shows steady growth and healthy financials. From 2018 to 2023, the company’s sales volume increased from 5.4 K Units to 7.8 K Units, demonstrating the continued demand for its products in the market and the company’s aggressive expansion in sales. In terms of price, FUJIFILM Medical Systems’ price per unit decreased slightly from $138.7 thousand per unit in 2018 to $132.3 thousand per unit in 2023, which may be due to competition in the market, cost control, or changes in product pricing strategies. Despite the decrease in unit price, the Company’s operating income increased from $75 Million in 2018 to $103 Million in 2023, reflecting the positive impact of increased sales volume on the Company’s total revenue. In terms of gross margins, FUJIFILM Medical Systems has maintained high levels, consistently above 73% despite fluctuations in different years, reaching 76.35% in 2023. These figures show that FUJIFILM Medical Systems has struck a balance between increasing sales and maintaining profitability.
Table FUJIFILM Medical Systems Flexible Endoscopy Equipment Sales Volume, Price, Revenue, Gross Margin (2018-2023)
FUJIFILM Medical Systems | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Sales (K Units) | 5.4 | 5.6 | 5.1 | 6.4 | 7.1 | 7.8 |
Price (K USD/Unit) | 138.7 | 137.1 | 140.4 | 136.9 | 133.7 | 132.3 |
Revenue (M USD) | 0.75 | 0.76 | 0.72 | 0.87 | 0.96 | 1.03 |
Gross (M USD) | 0.58 | 0.63 | 0.57 | 0.64 | 0.71 | 0.79 |
Gross Margin | 77.64% | 81.99% | 79.05% | 73.01% | 74.36% | 76.35% |
